A hypothesis: Edaravone exert cardioprotection partly via modulation of adiponectin

Medical Hypotheses

Volumn 79, Issue 2, 2012, Pages 141-142

  Pei, Haifeng ^a   Jia, Min ^a   Sun, Lu ^a   Zheng, Xiaohui ^a   Zhou, Haiyan ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; NORPHENAZONE; TUMOR NECROSIS FACTOR ALPHA;

ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; DRUG EFFECT; DRUG MECHANISM; HEART PROTECTION; HUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADIPONECTIN; ANTIPYRINE; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; FREE RADICAL SCAVENGERS; HUMANS; MODELS, IMMUNOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863314552     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.04.015     Document Type: Article

References (20)

1. Higashi Y., Jitsuiki D., Chayama K., et al. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 2006, 1:85-93.
2. Firuzi O., Miri R., Tavakkoli M., et al. Antioxidant therapy: current status and future prospects. Curr Med Chem 2011, 18:3871-3888.
3. Saini A.K., Patel R.J., Sharma S.S., et al. Edaravone attenuates hydroxyl radical stress and augmented angiotensin II response in diabetic rats. Pharmacol Res 2006, 54:6-10.
4. Fukudome D., Matsuda M., Kawasaki T., et al. The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice. Eur J Pharmacol 2008, 583:164-169.
5. Saini A.K., Kumar H.S.A., Sharma S.S. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy. Eur J Pharmacol 2007, 568:164-172.
6. Nagatani S., Sudo T., Murakami Y., et al. Edaravone, a free radical scavenger, promotes engraftment of intraportally transplanted islet cells. Pancreas 2011, 40:126-130.
7. Ohmasa F., Saito M., Tsounapi P., et al. Edaravone ameliorates diabetes-induced dysfunction of NO-induced relaxation in corpus cavernosum smooth muscle in the rat. J Sex Med 2011, 8:1638-1649.
8. Chiariello M., Indolfi C. Silent myocardial ischemia in patients with diabetes mellitus. Circulation 1996, 93:2089-2091.
9. Kikuchi K., Uchikado H., Miyagi N., et al. Beyond neurological disease: new targets for edaravone (Review). Int J Mol Med 2011, 28:899-906.
10. Yamazaki K., Miwa S., Toyokuni S., et al. Effect of edaravone, a novel free radical scavenger, supplemented to cardioplegia on myocardial function after cardioplegic arrest: in vitro study of isolated rat heart. Heart Vessels 2009, 24:228-235.
11. Yamawaki M., Sasaki N., Shimoyama M., et al. Protective effect of edaravone against hypoxia-reoxygenation injury in rabbit cardiomyocytes. Br J Pharmacol 2004, 142:618-626.
12. Nimata M., Okabe T.A., Hattori M., et al. MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats. Am J Physiol Heart Circ Physiol 2005, 289:H2514-H2518.
13. Ouchi N., Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta 2007, 380:24-30.
14. Shibata R., Sato K., Pimentel D.R., et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 2005, 11:1096-1103.
15. Tao L., Gao E., Jiao X., et al. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 2007, 115:1408-1416.
16. Onimaru S., Nakamura K., Kariyazono H., et al. Inhibitory effects of edaravone on the production of tumor necrosis factor-alpha in the isolated heart undergoing ischemia and reperfusion. Heart Vessels 2006, 21:108-115.
17. Kern P.A., Di Gregorio G.B., Lu T., et al. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003, 52:1779-1785.
18. Meja K.K., Barnes P.J., Giembycz M.A. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation. Br J Pharmacol 1997, 122:149-155.
19. Liu S., Yin T., Wei X., et al. Downregulation of adiponectin induced by tumor necrosis factor α is involved in the aggravation of posttraumatic myocardial ischemia/reperfusion injury. Crit Care Med 2011, 39:1935-1943.
20. Hu S., Hu H., Lin H., et al. 70 cases: edaravone treatment for patients with cerebral infarction. Herald Med 2011, 30:1046-1048.